Circulating Tumor Cells May Predict Melanoma Relapse Circulating Tumor Cells May Predict Melanoma Relapse

In patients with stage III melanoma, levels of circulating tumor cells (CTCs) may predict relapse, potentially allowing for identification of individuals who could benefit from close surveillance or adjuvant therapy, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news